EBV immunological agent

BIOLOGICAL2 trials

Sponsors

West China Hospital

Conditions

CAEBV (Chronic Active Epstein-Barr Virus Infection) SyndromeMalignant TumorPTLDs

Phase 1

Clinical Study of Therapeutic Immunological Agent for EBV-positive Advanced Malignant Tumors

Active, not recruitingNCT05707910

West China HospitalMalignant Tumor

Start: 2023-02-08End: 2027-12-31Updated: 2026-03-09

Clinical Study of Therapeutic Immunological Agent for EBV Lymphoproliferative Diseases

Not yet recruitingNCT06666153

West China HospitalCAEBV (Chronic Active Epstein-Barr Virus Infection) Syndrome, PTLDs

Start: 2024-10-31End: 2026-12-31Target: 27Updated: 2024-10-30